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CHAPTER	  1:	  INTRODUCTION	  
	  
 The emerging field of studying epigenetics via nutrition –mediated 
perspective has been enriching our knowledge and expanding our understanding 
of how to maintain our health and how to modify diets to improve our health. The 
relationship between nutrition and epigenetics becomes particularly important 
when considered within the context of individuals with genetic disorders, such as 
individual with Down syndrome. Understanding the role of nutrition plays in Down 
syndrome could help in the development and implementation of strategies that 
help overcome the negative consequences phenotypes of Down syndrome. 
Conserving genome integrity is crucial for cells to survive, and thus 
understanding how genetic defects induce damage to genomic DNA and impair 
subsequent repair of this damage is important. Evidence accumulated points to 
increased DNA damage and mutation accumulation associated with a decline in 
DNA repair capacity, Base Excision Repair (BER) in particular. Many 
experiments have demonstrated that elevated levels of chromosome 21-linked 
gene products (HSA21) are correlated to the increase level of DNA damage and 
decrease level of BER in DS. Thus, the successful clinical management of DS 
resides in understanding the metabolic imbalance provoked by overexpression of 
genes on chromosome 21.   
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  A.	  	  Down	  syndrome	  (DS):	  	  
Trisomy 21,DS, is a complex metabolic and genetic disorder that stems 
from the failure of chromosome 21(HSA21) to segregate normally during meiosis 
[1]. The origin of the extra copy of HSA21 has been related to the maternal 
chromosome in 93% of cases, and to the paternal chromosome in 7% of cases 
[6]. DS is the most common genetic cause of intellectual disability and is 
characterized by accelerated aging [2], and has an incidence of 1~1/700 live birth 
[3]. Individuals born with DS exhibit phenotypes with varying severity of cognitive 
impairment, craniofacial dysmorphology, heart defects [3], and immunologic 
disorders, such celiac disease and diabetes [1]. It is assumed that the excess 
products derived from overexpression of multiple genes located on HSA21 is the 
underlying factor for the abnormality in the nervous, endocrine, and immune 
system which are features of DS [3,4]. However, recent studies suggest that 
certain tissues and gene product are more sensitive than others to gene dosage 
effects. Sod1, the gene that encodes Superoxide dismutase 1, is one example of 
a gene that is well documented to be overexpressed in DS [5]; there is a 
significant increase in Sod1 activity between 1.4 and 1.8 times higher in trisomic 
cells than normal lymphocyte cells [5]. ATP-binding cassette, subfamily G, 
member 1(ABCG1) was found to be 2.67 fold overexpressed in adult DS brain 
tissue [55], whereas it was only 1.25 overexpressed in DS lymphocyte cells [56]   
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B.	  	  DNA	  damage;	  Genome	  Instability:	  	  
Preserving and maintain genome integrity is crucial for survival of cells. 
The integrity and identity of the genome is challenged by the incorporation of 
aberrant molecules unrelated to genomic DNA such as ribonucleoside 
triphosphate (rNTPs) in plase of deoxyribonucleoside triphosphate (dNTPs) 
during replication [7], or an altered base like uracil. This misincorporation of the 
aberrant molecules prompts DNA repair machineries to fix the damage and 
restore genome integrity; otherwise, the lesions formed convert to mutation 
disrupting cells survival. Evidence indicates a linkage between aging and nuclear 
DNA lesions; premature aging can be a result of DNA damage accumulation with 
age associated with DNA repair defects [57]. Various aging biomarkers are seen 
in DS, including oxidative stress, mutation accumulation and reduced DNA repair 
[58]. 
	  	  	  	  	  	  	  	  	  	  B.1	  Uracil:	  
Uracil is a natural base present in RNA structure; however, it may arise in 
DNA via two distinctive pathways. First pathway is through deamination of 
cytosine, and second pathway through misincorporation of deoxyuridine 5’-
triphosphate nucleotide (dUTP) in place of thymidine 5’-triphosphate (dTTP) 
during DNA replication. The incorporation of dUTP into DNA during replication 
phase has been estimated to be up to 104 uracil residues in human genome per 
day [8]. This incorporation of uracil creates DNA lesions, and such lesions are 
cleared out through high fidelity DNA repair mechanism and thus preventing 
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genome injury [8]. Deoxyuridine 5’- triphospatase nucleotide hydrolase 
(dUTPase) regulates the dUTP/dTTP ratio. dUTP is synthesized in eukaryotic 
cells from the phosphorylation of dUDP , which in turn arise from either UDP 
undergoing the action of ribonucleoside diphosphate reductase (rNDP)  or from 
the phosphorylation of dUMP by nucleoside diphosphate kinase (NDPK)  , an 
essential intermediate for the synthesis of the intracellular dTTP pool and thus is 
a permanent source of dUTP, as shown in Figure 1.1 [9].  
	  	  	  	  	  	  	  	  	  	  B.2	  Ribonucleotide	  misincorporation:	  
Rribonucleotides (rNTPs) have been shown to be misincorporated in yeast 
DNA during replication at a high rate, demonstrating that replicative polymerases 
do not exclude rNTP absolutely [34]. Okazaki fragments in RNA primers or 
RNA/DNA hybrid are another source of rNTP, which arise when nascent RNAs 
base pair with their template to prime DNA synthesis from the discontinuous 
strand [34]. 
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Figure 1. 1 De novo synthesis of Deoxynucleotides 
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C.	  MicroRNA	  -­‐155:	  	  
 MicroRNAs (miRNAs) are class of small noncoding RNAs, 19-24 
nucleotides, produced from genes encoding RNAs with a hairpin secondary 
structure [10,11]. These hairpin RNAs are then processed to produce mature 
single stranded miRNAs that become incorporated into many different protein 
complexes. These miRNAs bind to a complementary sequence located in the 3’- 
translated regions (3’ UTRs) of messenger RNAs (mRNAs), and can regulate the 
expression of large group of genes at post- transcriptional level via various 
mechanism such as cleavage, degradation, cell cycle control, translational 
inhibition, and mRNA transport [10].  
 miR-155 is a product of MIRN155 gene in humans or Bic in mice, and is 
located on chromosome 21 [10,11,12]. Strong evidence indicates that miR-155 
plays an essential role in biological process including hematopoiesis, 
inflammation, and immune modulation [11], and its expression is induced in 
activated leukocytes and germinal center of B cells [10]. Deregulation of miR-155 
has been linked to different kind of cancer, cardiovascular diseases and viral 
infection [11]. It was found that miR-155 expression is highly increased in 
activated B and T cells, and found to be required for lymphocyte development 
and generation of B-cell receptors (BCRs) and T-cell receptors (TCRs) activation 
in vivo [11]. Mice deficient in miR-155 experience deregulation of expression of 
hundreds of mRNAs, some of which are direct targets of miR-155 leading to vast 
abnormalities in the germinal center reaction and antibody responses in vivo [10]. 
miR-155 has been shown to target over 60 different genes in B- cells. Recently, 
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AID gene, which is restricted to activated B cells, has been identified, as an 
important target of miR-155 in vivo, and solid evidence points that miRNA-155 as 
a negative regulator of AID [11]. Hence, the significant role in controlling the 
germinal center reaction of miR-155 in B-cells found to be at least in part related 
to its role in suppression AID expression [13]. Also, expression of AID gene was 
found to be 1.6 fold increased in miR-155 deficient b-cells [14]. People with Down 
syndrome have aberrant miR-155 expression due to the extra copy of 
chromosome 21 [15]. miR-155 was found to be triplicated and over expressed  in 
Ts65Dn mouse model of down syndrome [2,15].   
D.	  AID;	  Role	  in	  Somatic	  Hyper	  Mutation:	  
In response to foreign pathogens, B cells induce diversity of the anti 
bodies by mutating their genome through Somatic hyper mutation (SMH) [16]. 
This mechanism is tightly regulated by activation induced cydtidene deaminase 
(AID). AID promotes diversity by converting cytosine to uracil within the 
immunoglobulin loci [17], producing U:A mismatch, which is non-mutagenic, or 
U:G mispair, which is mutagenic. This deoxyuracil residue is mutagenic if paired 
with deoxyguanosine since it mimics thymidine during DNA replication, and will 
promote C>T mutagenesis. Although U:A mispairs are not mutagenic, they are 
followed by the removal of uracil base by Uracil DNA glycosylase (UNG2), which 
generates a transient DNA strand break. Therefore, a critical intermediate in this 
process is the appearance of strand breaks and the loss of DNA integrity. Almost 
60% of mutation accumulated in vivo in mice and human are in A:T bases, and 
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are not caused by the direction of AID Figure 1.3 [18]. Once AID has altered dC 
to dU in DNA, uracil is either replicated or removed by UNG to create an abasic 
site, which can be converted into a single strand break. This single-stranded 
break recruits error prone polymerases for further repair. Whereas replication 
generates only transition mutation, UNG-dependent pathway can generate 
transition and transversion mutation Figure 1.2 [19]. 
The results from (Poltoratsky et al, 2007) showed that down-regulation of 
the normal BER gap-filling DNA polymerase, Polβ, in the somatic hypermutation 
(SHM) proficient B cell lines (BL2 cells). This is consistent with the hypothesis 
that normal error-free BER must be silenced to make way for an error-prone BER 
process that may be required during SHM [23].  
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Figure 1. 2 Mutation generated by AID activity 
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Figure 1. 3 A model for Somatic Hypermutation (SHM) 
(Peled et al.) [18]	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E.	  Uracil	  -­‐DNA	  Glycosylase:	   
The fact that multiple uracil-DNA glycosylase (UDG) enzymes exist across 
vast variety of species (bacteria, archaea, and eukaryotes) [20], and the fact that 
are conserved in all types of human cells [21] support the significance of 
removing uracil from the genome.   The UNG gene encodes human UDG protein; 
this gene produces two different isoforms, mitochondrial UNG1 and nuclear 
UNG2, due to the alternative promoter usage and splicing of this gene [21]. 
UNG2 is the most dominant form in the cells illustrating more than 90% of the 
total activity of this enzyme [22]. Nuclear UDG activity is cell cycle- dependent 
and increases during S-phase [21]. Mice lacking UNG2 have an increased level 
of uracil in their DNA, and UNG2 enzyme was shown to be the principle uracil-
DNA glycosylase responsible for the excision of uracil and the formation of U:G 
lesions in mouse [20]. UDG is able specifically to process the mutagenic U:G 
lesions, resulting from spontaneous deamination of cytosine, which specifically 
relates to immunoglobulin diversification during SHM and CSR [20]. The 
important role of UDG in eliminating uracil from DNA arises from the fact that 
DNA polymerases are poor discriminators between dTTP and dUTP, a precursor 
of dTTP in de novo biosynthesis pathway, so that dUMP will be misincorporated 
into the newly synthesized DNA in corresponding to the increasing dUTP pool.  
The resultant U:A pair in the daughter DNA is neither mutagenic nor cytotoxic, 
yet it has deleterious effects including changing the affinity of DNA-binding factor 
for its target sequence [24]. Additionally, excision of the U from the U:A mispair 
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will generate a transient DNA break. UDG catalyzes the excision of uracil and 
initiates DNA base Excision repair (BER) [25]. Once uracil is excised by UDG, 
the abasic site is efficiently converted to a transient single strand break by 
apurinic/apyrimidinc endonuclease (APE1). This abasic site can be repaired 
further by error-prone polymerases such as DNA polymerase κ, η, and ι , or by 
error –free polymerases such as DNA polymerase β (POL β) [18].   
F.	  Base	  Excision	  Repairer	  (BER):	  	  
BER is a DNA repair mechanism, by which damaged bases are excised by DNA 
glycosylase, followed by several subsequent steps to repair the lesion [18]. 
 Error –prone repair is essential feature in SHM and CSR, restricted to the 
non-replicative phases, whereas error-free repair is crucial for DNA replication 
during the S phase of the cell cycle. Error free BER is commonly initiated by 
UNG2 leading to an abasic site (AP-site) that is Further cleaved on its 5’ side by 
an apurinic/apyrimidinic (AP)-endunuclease (APE), leaving a free 3’-OH end a 5’-
deoxyribose phosphate (dRP) group. The dRP group is then incised on its 3’ side 
via the lyase activity (dRpase) of the DNA polymerase β (Pol β) for short patch 
repair pathway whereas a short oligonucleotide is cleaved by flap endonuclease 
1 (FEN1) for the long patch repair pathway. The resulting gap, finally, is filled by 
pol β/ or pol δ/ε   and sealed by DNA Ligase III or I [18,27].  
 Since the damage generated by AID creates single base G:U mismatches, 
and since short-patch BER generates single abasic site mismatches, enzymes 
that recognizes larger mismatches, such as Msh3, have little effect on SHM [18]. 
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G.	  Folate	  Deficiency;	  One	  Carbon	  Metabolism	  Pathway: 
 Adequate intake of Folate is crucial for cell division and homeostasis due 
to the vital role of folate coenzymes in nucleic acid synthesis, methionine 
regeneration, oxidation and reduction of one-carbon units required for normal 
metabolism and regulation [28]. Folate deficiency has been shown to impair DNA 
excision repair and mismatch repair [26,28,29], and elevates homocystenie 
levels, which in turn increase oxidative stress [30]. 
 Tetrahydrofolate (THF) is the naturally occurring reduced form of folate 
[31]. Folate is metabolized via one carbon metabolism pathways, which 
collectively include purine and pyrimidine synthesis, formation of the primary 
methylating agent, S-adenosylmethionine (SAM) [28]; the amino acids 
methionine, serine, glycine, and histidine are, also, metabolized through folate-
dependent reactions [31]. 
 The main function of folate coenzymes is to accept or donate one-carbon 
units in key metabolic pathways (Figure 1.4), and the central folate acceptor 
molecule is THF. The conversion of THF to 5,10-methylene-THF is the first 
essential step that drives the cycle in which the one carbon unit from serine, as a 
major carbon source, is transferred to THF via serine hydroxymethyltransferase 
(SHMT) to form 5,10- methylene-THF and glycine. A portion of 5,10- methylene-
THF is oxidized by methylene tetrahydrofolate reductase (MTHFR) to form 5-
methyl-THF.  The N-5-methyl group of 5-methyl-THF can only be transferred to 
homocystenie for regeneration/remethylation of methionine. MTHFR plays a key 
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role in one-carbon metabolism by directing the methylation step of homocystenie 
[1,32] 
	  
Figure 1. 4 Folate one-carbom metabolism 
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 Overexpression of CBS gene, located on chromosome 21, leads to 
increase transculturation pathway, which in turn indirectly deprives methionine 
synthase reaction of homocysteine leading to the accumulation of 5-MTHF. This 
exponential conversion of homocystenie to cysteine and reduction level of 
methionine synthase activity thus creates the well established “methyl trap” [1]. 
As the increase of transsulfuration activity of converting homocysteine to cysteine 
requires B6 as cofactor, the bioavailability of B6 as co factor in conversion THF 
to 5,10-methylene-THF is compromised leading to the accumulation of THF, 
which is the well-established “Folate trap”, functional folate deficiency [1,32], and 
directing the folate coenzymes away from the cycle that produce purine and 
pyrimidine for DNA synthesis [33]. 
 Folate deficiency, as source of endogenous DNA damage, causes an 
imbalance in the thymidine/uracil ratio leading to uracil being incorporated into 
DNA during synthesis. The repair of two nerby opposing lesions can cause DNA 
double strand breaks (DSBs), which are considered the most lethal DNA lesion 
[28].  
H.	  RNaseH2;	  Ribonucleotide	  Excision	  Repair:	  
The presence of a single reactive hydroxyl group at the 2’ position of 
ribose sugar of a ribonucleotide (rNTP) makes rNTPs susceptible to spontaneous 
hydrolysis [35]. Thus, the incorporation of rNTP in genomic DNA increases its 
susceptibility to breakage. Even though replicative DNA polymerases have 
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extraordinary ability to distinguish and favor deoxyribonucleotide (dNTP) 
selection over rNTP election, DNA polymerases can and do incorporate rNTP 
into DNA [38]. Under conditions where rNTP:dNTP imbalance exists in the cell, 
this misinsertion of rNTPs by polymerases is accelerated. Such incorporation of 
rNTP in DNA is expected to trigger removal and repair machinery catalyzed by 
Ribonuclease H2 (RNaseH2) [34]. Other sources of ribonucleotide in DNA are 
Okazaki fragment of RNA primers, which ascend from base pairing with nascent 
RNA transcript with their template [35]. 
RNaseH2 is a member of a family of endonucleases that cleave RNA 
moiety in RNA: DNA hybrids, following the reconstruction of double strand 
molecule [36]. Inactivation of RNaseH2 leads to accumulation of RNA/DNA 
hybrids that in turn activates innate immune response [37]. RNaseH2 is a 
complex of three subunits: RNaseH2A, RNaseH2B, and RNaseH2C; RNaseH2A 
contains the catalytic center, whereas RNaseH2B and RNaseH2C are more 
likely to interact with other proteins [38].  
Mutation in RNaseH2 results in Aicardi-Goutières syndrome (AGS), which 
is a pediatric neuroinflammatory disorder of intrauterine viral infection [35], and 
has immunological similarities to autoimmune disease systemic lupus 
erythematous [38].  
RNaseH2 recognizes single ribonucleotide in DNA, suggesting its role in 
removing and repairing single ribonucleotides embedded within double strand 
DNA [35,39]. In absence of RNaseH2, misincorporated ribonucleotides are 
processed by topoisomerase Ι (topo I), which is responsible for increasing 
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mutation rate in part [39]. An estimate rate of at least 1 rNTP incorporated every 
7,600 nt in RNaseH2 null cells, corresponding to ~ 1,300,00 lesions per cells [38] 
 
	  
Figure 1. 5 A model of Ribonucleotide Excision Repair (RER) 
 
Ribonucleotide Excision repair (RER) is most efficient when rNTP is 
incised by RNaseH2 and excised by flap endonuclease FEN1 generating a single 
nucleotide gap that is further processed with strand displacement synthesis 
carried out by DNA polymerase δ, PCNA clamp, its loader RFC, and completed 
by DNA ligase I (Figure 1.5) [40, 41].  
 
(Sparks et al.)[41] 
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CHAPTER	  2:	  HYPOTHESIS	  AND	  SPECIFIC	  AIMS	  
	   	  Overexpression of genes coding specific enzymes in Down syndrome 
(DS) as a result of trisomy 21 affects multiple interacting metabolic pathways that 
leads to cellular dysfunction and contributes to the unique pathogenesis and 
dysmorphic characteristics of the neurological, immunological, and biochemical 
abnormalities in DS [4,42]. Individuals with DS exhibit DNA damage 
accumulation, mutation accumulation and chromosomal sensitivity to mutagens 
[2]. In addition, Evidence accumulated indicates the inherent defect of DNA 
repair and BER capacity in DS [2,43]. Several studies point to the low level of 
DNA polymeraseβ and BER capacity associated with low level of thymidine 
incorporation in DNA. The integrity of the genome is challenged by the 
incorporation of anomalous substrates such the incorporation of ribonucleotides 
(rNTPs) in place of deoxyribonucleotides (dNTPs) during replication or the 
incorporation of uracil in DNA by spontaneous deamination of cytosine during 
antibody diversification induced by activity of AID gene [44,46], which is a direct 
target for miR-155 [10,45], Moreover, Folate depletion facilitates uracil and 
ribonucleotide misincorporation in DNA due to the significant role of Folate in one 
carbon metabolism pathway. This integration of aberrant molecules is the most 
frequent DNA lesions triggering different repairing mechanisms to preserve 
genome integrity. Furthermore, high levels of cystathionine β-synthase (CBS) 
alters homocystine metabolism compromising the Folate –dependent resynthesis 
of methionine [1,42].  The decreased availability of homocystine, which is 
associated with DS, promotes the well –established “Folate Trap” as a functional 
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Folate deficiency [1]. The fact that miR-155, and CBS genes, located on 
chromosome 21(HSA21) are over expressed in people with DS [1,42] leads us to 
investigate the effect of the excessive products of these two genes and folate 
depletion on DNA lesions formation and subsequent repair pathways in 
Lymphoblastoid cells.  
 We developed a model to test our hypothesis that a mechanism derived 
by the high dosage of MIR155 and CBS genes present on chromosome 21 
could be the underlying mechanism for reducing BER activity and 
thymidine incorporation in human Down syndrome lymphocytes. This 
hypothesis is tested in the following Specific Aims: 
Specific Aim 1:  we will test whether over expression of miR-155 is associated 
with reduced AID gene expression in DS B-lymphocytes.  
Specific Aim 2:  We will test whether folate depletion reduces dNTP levels and 
induces RNaseH2 expression in normal B-lymphocytes. 
Specific Aim 3: We will test whether gene-dosage overexpression of CBS gene 
is associated with RNaseH2 expression in DS B-lymphocytes.  
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CHAPTER	  3:	  MATERIALS	  AND	  METHODS	  
A. Cell Culture:  
Epstein Barr Virus (EBV) – transformed human Lymphoblastoid cell lines 
(LCLs) obtained from Coriell Cell Repsitories. Two types were used in this 
project, down syndrome (DS) and non –down syndrome (NDS). The cells were 
cultured in Roswell Park Memorial Institute (RPMI) 1640 growth medium 
containing 15% non- dialyzed Fetal Bovine Serum (FBS), 0.5% glutamine, and 
1% antibiotic. The cells were grown at 37ºC and 5% CO2 atmosphere. The NDS 
cells were also grown under different conditions; Folate added (FA) and Folate 
depleted (FD) using RPMI1640 media deficient in Folic acid at 37ºC and 5% CO2 
atmosphere. The cells were cultured for 3 passages and grown to 75 ~80% 
confluency before each passage. 
B. RNA Isolation/ cDNA Synthesis: 
 Once the cells had been harvested, the total RNA was isolated using 
Trizol® Reagent protocols. Starting with 2µg of isolated RNA, cDNA was 
synthesized using random hexamer primer and reverse transcriptase. The newly 
synthesized cDNA was then purified using PureLink® PCR Purification Kit.   
C. MicroRNA Assay: 
 Having been isolated and purified, RNA was reverse transcribed by stem- 
loop primer using TaqMan micro RNA assay®. Then, performing RT-PCR 
amplification. Data were analyzed by Δ CT method and presented as fold 
change.  
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D. Quantitative Rt-PCR analysis:  
 The expressions of the genes of interest were quantified via Real-time 
polymerase chain reaction using LightCycler®480 instrument (Roche, 
Indianapolis, IN), Light Cycler® 480 SYBR Green I Master, the resultant cDNAs, 
and gene- specific primers. The data were normalized to the to geometric mean 
of the house keeping genes: GAPDH and HPRT1 for accurate normalization and 
optimization [47]. All RT-PCR products were then run on 1.5 % agarose gel 
electrophoresis for further verification. 
E. Gene cloning: 
 Genes were cloned using TOPO® TA Cloning® Kit, and GeneJET Plasmid 
Miniprep Kit or Wizard® Plus Midipreps DNA Purification System for plasmid 
isolation and purification. The sequences of the genes were confirmed via the 
sequencing core at Wayne state university, Applied Genomic Technology Center 
(AGTC), Detroit, MI. 
F. Folate microbiology Assay:  
 Lactobacillus Casei microbiological assay were used to detect the Folate 
status and to confirm depletion of Folate in FD cells. L. casei bacteria were 
grown overnight in growth media supplemented with folic acid. After harvesting 
bacteria, the plate was setup by adding 18 µl of working buffer, which is 3.2 g 
sodium ascorbate + 1 M potassium phosphate buffer PH 6.1), 150µl of the single 
strength folic acid casei medium, the sample (1µl), then we add distilled water to 
adjust the total volume to 180ul. Finally, we add 20µl diluted L. casei inoculums 
to each well.  The plate is then covered with polystyrene cover and aluminum foil, 
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and incubated at 37˚C for about 21hrs, and read at 595nm in the model Genios 
basic of TECAN-GENios plus plate reader with the software TECAN megellan 
v6.00. The results were analyzed using the t-test (p< 0.05). [48] 
G. LC-MC/MC Analysis: 
 Intracellular nucleoside triphosphate and deoxynucleoside triphosphate 
was determined via Karmanos Cancer Institute, Pharmacology Core Laboratory, 
Detroit, MI 48120, using LC-MS/MS method SOP for preparing cell pellete 
samples. 
H. Statistical Analysis: 
 Data are presented as Mean ± SEM and analyzed using (unpaired) 
t-test. Values of p < 0.05 were considered significant 
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CHAPTER	  4:	  RESULTS/	  FIGURES	  
Figure 4. 1 Relative SOD1 gene expression across LCLs (DS and NDS) 
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Figure 4.1: Relative SOD1 expression across LCLs (DS and NDS). RNAs were 
isolated from cells grown for 3 passages. SOD1 gene expression was determined 
by RT-PCR. Data were normalized to GAPDH (A), and to HPRT1 (B). Data were 
triplicated and presented as mean ±SEM. 
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Figure 4. 2 Selection of appropriate LCLs (DS and NDS) for the experiment. 
 	  
Figure 4.2 Selection of appropriate LCLs (DS and NDS) for the 
experiment. SOD1 gene used as control gene is up regulated in trisomy 21. 
RNAs were isolated from cells grown for 3 passages. SOD1 gene expression 
was determined by RT-PCR. Data were normalized to the geometric mean of 
Housekeeping genes (HPRT1 and GAPDH) as described in the methods. 
Data were triplicated and presented as mean ±SEM. Cells are age matched, 
labeled with (*), were selected as models for our experiment. 
  
Male	  	   Male	  	   Male	  	   Male	   Male	  	  
21yr	   25yr	   27yr	   23yr	   27yr	  
NDS	   NDS	   NDS	   DS	   DS	  
GM16118	   GM00130	   GM16113	   GM01921	   GM04927	  
Mean	   1.73E+00	   1.91E+00	   2.06E+00	   3.74E+00	   2.80E+00	  
0.00E+00	  
5.00E-­‐01	  
1.00E+00	  
1.50E+00	  
2.00E+00	  
2.50E+00	  
3.00E+00	  
3.50E+00	  
4.00E+00	  
Re
la
ti
ve
	  S
O
D
1	  
ex
pr
es
si
on
/n
or
m
al
iz
ed
	  
SOD1	  	  
*	  
*	  
	  	  
27	  
Figure 4. 3 Elevated SOD1 gene expression in DS cells 
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Figure 4.3: Elevated SOD1 gene expression in DS cells. RNAs 
were collected from 2 sets (A,B) of DS and NDS cells grown for 3 
passages.  Gene expression was determined by RT- qPCR . Data 
were normalized to the geometric mean of HPRT1 and GAPDH. 
Data were triplicated and presented as mean ± SEM.  Statistical 
significant was determined via T-test. NDS is non-DS cell line 
(GM16113), DS is DS cell line (GM04927) .A. p< 0.001, SOD1 was 
elevated 1.4 Fold in DS. B. **p< 0.0001, Sod1 was elevated 1.4 fold 
in DS. 
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Figure 4. 4 MIR155 expression in DS and NDS cells 
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Figure	  4.4:	  MIR155	  expression	  in	  DS	  and	  NDS	  cells.	  MIR155	  expression	  
is	  highly	  expressed	  in	  DS	  cells.	  RNAs were isolated from cells grown 
for 3 passages. Mir-155 was transcribed as we describe in 
methods. MIR155 expression was determined by RT-qPCR 
analysis. Data were normalized to U6 gene. Data were triplicated 
and presented, as mean ± SEM. Statistical significant was 
determined via T-test. **p< 0.0001.	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Figure 4. 5 Relative AID gene expression in DS cells 
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Figure 4.5: Relative AID gene expression in DS cell. AID gene 
was almost 50% depressed in DS cells. RNAs were isolated from 
cells grown for 3 passages. AID expression was determined by RT-
qPCR analysis. Data were normalized to the geometric mean of 
HPRT1 and GAPDH. Data were triplicated and presented, as mean 
± SEM. Statistical significant was determined via T-test. p< 0.0001. 
AID relative expression was depressed 0.43 fold in DS cells 
comparing to NDS. 
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Figure 4. 6 Relative UNG2 gene expression in DS cells. 
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Figure 4.6: Relative UNG2 gene expression in DS cells. UNG2 was 
more than 50% depressed in DS cells. RNAs were isolated from cells 
grown for 3 passages. UNG2 expression was determined by RT-qPCR 
analysis. Data were normalized to the geometric mean of HPRT1 and 
GAPDH. Data were triplicated and presented, as mean ± SEM. 
Statistical significant was determined via T-test. *p< 0.01. UNG2 
relative expression was depressed 0.68 fold in DS cells comparing to 
NDS. 
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Figure 4. 7 Relative expression of POLB gene in DS and NDS cells. 
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Figure 4.7: Relative expression of POLβ gene in DS and NDS 
cells. RNAs were isolated from cells grown for 3 passages. POLβ 
expression was determined by RT-qPCR analysis. Data were 
normalized to the geometric mean of HPRT1 and GAPDH. Data 
were triplicated and presented, as mean ± SEM. Statistical 
significant was determined via T-test. POLβ relative expression was 
down regulated 0.88 fold in DS cells comparing to NDS, yet does 
not show significant difference, T-test = 0.2959. 
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Figure 4. 8 Overexpression of CBS gene in DS cells 
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Figure	  4.8:	  Overexpression	  of	  CBS	  gene	   in	  DS	  cells.	  RNAs were isolated 
from cells grown for 3 passages. CBS expression was determined by 
RT-qPCR analysis. Data were normalized to the geometric mean of 
HPRT1 and GAPDH. Data were triplicated and presented, as mean ± 
SEM. Statistical significant was determined via T-test. **p< 0.0001. 
CBS relative expression was elevated 2.2 fold in DS cells comparing 
to NDS. 	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Figure 4. 9 Relative Folate level in response to Folate depletion in normal 
LCLs. 
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Figure 4.9: Relative Folate levels in response to Folate 
Depletion in normal LCLs. Cells were grown in absence and 
presence of Folate Absence of Folic acid in media used for FD cells 
deplete folate cellular level unlike FA. Folate level in normal B- cells 
was measured using the microbiological assay as described in 
methods. Data were triplicated and presented, as mean ± SEM. 
Statistical significant was determined via T-test (*p value < 0.01.) 
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Figure 4. 10 Relatve dNTP levels in response to Folate depletion in normal 
LCLs. 
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Figure 4.10: Relative dNTP levels in response to Folate 
Depletion in normal LCLs. Folate depletion reduced total dNTPs 
level. Cells were grown in absence and presence of Folate. 
Intercellular deoxyribonucleotides were measured by LC-MS/MS 
Analysis as described in methods. *p<0.05. 
* 
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Figure 4. 11 Relative AID gene expression in response to Folate depletion 
in Normal LCLs. 
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Figure 4.11: Relative AID gene expression in response to Folate 
Depletion in normal LCLs. Folate depletion induces AID 
expression. Cells were grown in absence and presence of Folate. 
RNAs were isolated from cells grown for 3 passages. AID 
expression was determined by RT-qPCR analysis. Data were 
normalized to the geometric mean of HPRT1 and GAPDH. Data 
were replicated and presented, as mean ± SEM. Statistical 
significant was determined via T-test. **p< 0.0001. AID relative 
expression was elevated 4.00 fold in FD cells comparing to control 
FA. 	  
** 
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Figure 4. 12 Relative UNG2 expression in response to folate depletion in 
normal LCLs. 
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Figure	   4.12:Relative	   UNG2	   expression	   in	   response	   to	   folate	   depletion	   in	  
normal	   LCLs.	   Folate	   depletion	   induces UNG2 expression. Cells were 
grown in absence and presence of Folate. RNAs were isolated from 
cells grown for 3 passages. UNG2 expression was determined by RT-
qPCR analysis. Data were normalized to the geometric mean of 
HPRT1 and GAPDH. Data were replicated and presented, as mean ± 
SEM. Statistical significant was determined via T-test. **p< 0.0001. 
UNG2 relative expression was elevated 1.74 fold in FD cells 
comparing to control FA. 	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Figure 4. 13 Relative POLB expression in response to Folate depletion in 
normal LCLs 
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Figure	   4.13: Relative POLβ expression in response to Folate 
depletion in normal LCLs. Folate depletion induces POLβ 
expression. Cells were grown in absence and presence of Folate. 
RNAs were isolated from cells grown for 3 passages. POLβ 
expression was determined by RT-qPCR analysis. Data were 
normalized to the geometric mean of HPRT1 and GAPDH. Data 
were replicated and presented, as mean ± SEM. Statistical 
significant was determined via T-test. **p< 0.0001. POLβ relative 
expression was elevated 2.4 fold in FD cells comparing to control 
FA.  
** 
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Figure 4. 14 Relative RNaseH2 expression in response to Folate depletion 
in normal LCLs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure	   4.14: Relative RNaseH2 expression in response to Folate 
depletion in normal LCLs. Folate depletion induces RNaseH2 expressions. 
Cells were grown in absence and presence of Folate. RNAs were isolated 
from cells grown for 3 passages. RNaseH2 expressions for 3 subunits were 
determined by RT-qPCR analysis. Data were normalized to the geometric 
mean of HPRT1 and GAPDH. Data were replicated and presented, as mean 
± SEM. Statistical significant was determined via T-test. RNaseH2 A relative 
expression was elevated 1.98 fold in FD cells comparing to control FA,** p< 
0.0001. RNaseH2 B relative expression was elevated 1.7 fold in FD cells 
comparing to control FA, **p< 0.0001. RNaseH2 C relative expression was 
elevated 1.5 fold in FD cells comparing to control FA, yet not significant. T-
test= 0.0756. 
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Figure 4. 15 Relative RNaseH2 gene expression in DS cells. 
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Figure 4.15: Relative RNaseH2 gene expression in DS cells. RNAs were 
isolated from cells grown for 3 passages. RNaseH2 expressions for 3 sub units 
were determined by RT-qPCR analysis. Data were normalized to the geometric 
mean of HPRT1 and GAPDH. Data were triplicated and presented, as mean ± 
SEM. Statistical significant was determined via T-test. RNaseH2 A relative 
expression was elevated 1.32 fold in DS, **p<0.0001. RNaseH2 B relative 
expression was elevated 1.64 fold in DS, *p<0.01. RNaseH2 C relative 
expression was elevated 1.00 fold in DS, yet was not significant, T-test= 0.9362. 
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Figure 4. 16 Relative Folate level in DS and NDs B cells. 
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Figure 4.16: Relative Folate level in DS and NDS B cells. Cells 
were grown in presence of Folic acid in media. Folate level in B cells 
was measured using the microbiological assay as described in 
methods. Data were quadruplicated and presented, as mean ± 
SEM. Statistical significant was determined via T-test (*p value < 
0.05). DS cells were lower in total folate level by 0.76 fold in 
compared to NDS cells 
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CHAPTER	  5:	  DISSCUTION	  	  
 We screened SOD1 gene relative expression in five different cell lines; 
three non Down syndrome and two Down syndrome, in the purpose of selection 
good representative models for our experiments. We chose cell lines that were 
age-matched, and that overexpressed MIR155 in an appropriate dosage relative 
to gene triplication. Also, we normalized our data for two different valid 
housekeeping genes that are B-lymphocyte-specific, GAPDH and HPRT1, in 
order to find best reference gene as in Figure 4.1. Sod1 gene that encodes 
Superoxide dismutase 1 protein is localized on chromosome 21, and due to the 
fact that DS result in an extra copy of this chromosome, SOD1 is overexpressed 
in DS. While not all genes on Chromosome 21 exert gene-dosage effects in 
response to Trisomy 21, SOD1 is known to exert this gene dosage effect. As 
shown in Figures 4.1 and 4.2, we can truly see that these cell lines are 
appropriate lines to evaluate for DS phenotypes due to the elevation level of 
SOD1 over 1.4 fold compared to the NDS lines. We chose to move forward with 
analyses in two lines that were age matched as age-dependent effects of DS 
have been well-described. Further we normalized our data to the geometric 
mean of the previously selected house keeping genes, GAPDH and HPRT1 
according to Vandesopmele et al. [47] that using a single gene for normalization 
leads to relatively large error in significant proportion samples tested, and that 
using the geometric mean, not the arithmetic mean, of multiple carefully selected 
house keeping genes was validated as an accurate normalization factor. 
	  	  
42	  
 Figure 4.3 represents the significant differences level of Sod1 gene in DS 
cells comparing to NDS, and this observation was repeated for further 
verification. We can see that Sod1 gene was elevated 1.4 fold in DS cells, and 
this is consistent with previous experiments that reported that there is a 
significant increase in Sod1 activity between 1.4 and 1.8 times higher in trisomic 
cells than normal lymphocyte cells [3]. This is consistent with the anticipated 
gene-dosage effect, based on the presence of 3 copies of SOD1 in lieu of the 
normal 2 copies.  
 From Figure 4.4, the relative expression of miR-155 gene, which was 
measured using Δ Ct method as descried in methods, was elevated significantly 
in DS cells more than 1.7 fold, demonstrating a gene dosage effect for miR-155 
due to location on chromosome 21 as well. Also, there is evidence that miR-155 
is triplicated and over expressed in in Ts65Dn mouse model of Down syndrome 
as well [15].   
 AID gene is a direct target of miR-155, so the expression level of AID 
gene was examined in order to evaluate whether the high dosage of miR-155 in 
DS cell has an impact on AID expression. From Figure 4.5, AID gene was 
almost 50% depressed as compared to control cells, and the high level of miR-
155 could explain this observation. This finding was consistent with previously 
reported data that AID gene is subject to post-transcriptional regulation by miR-
155, and the main role of miR-155 in controlling the germinal center of B cell is 
due in part by repression of AID expression [10,13].  
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As miR-155 is considered a negative regulator of AID gene, this would 
lead us to anticipate that the lesions formed by AID activity are reduced, at least 
in part, so that the enzymes participating in excision and repairing these lesions, 
such as Uracil DNA Glycosylase (UDG) encoded by UNG2 gene, would be down 
regulated as well. Our data from Figure 4.6 confirm this hypothesis. UNG2 gene 
relative expression was significantly depressed more than 50% in DS cells 
comparing to the control cell, and this finding confirm also the reports that 
indicate UDG is specifically processes U: G lesions raised upon the activity of 
AID gene [49].  
Once UDG initiates BER by excision of the altered base and creation an 
abasic site, its activity catalyzes subsequent enzymes to repair the abasic site 
formed, via the base excision Repair (BER) pathway. Of these enzymes, DNA 
Polymerase β (POLβ) is of the utmost importance since it is the rate limiting 
enzyme for BER and its activity is error –free repair, short-patch repair, so it was 
important to investigate the level of expression of this enzyme. Figure 4.7 shows 
us that there was a trend of more than 50% down regulation of POLβ gene that 
encodes DNA polymerase β, yet this reduction was not statically significant as 
determined by T-test.  
CBS gene located on chromosome 21, which encodes cystathionine β-
synthase, is over expressed in trisomy 21. A 157% increase in CBS enzymes 
activity has been previously documented in individuals with DS [4,42]. Figure 
4.8, we can see that the extra copy of chromosome 21 on DS accounts for the 
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elevation level of CBS gene expression more than 2.2 fold comparing to the non 
DS cells.  
The elevation expression of CBS gene induces the so-called “Folate trap“, 
which induces a functional folate deficiency. The mechanism underlying the 
folate trap stems from the low level of homocytocine in DS as a result of elevated 
activity of cystathionine β-synthase, which converts homocysteine to 
cystathionine promoting accumulation of 5-methylterahydrofolate (5-MTHF) [1], 
which an essential precursor to drive the one carbon metabolism pathway. Upon 
the functional folate deficiency derived from CBS overexpression, we 
hypothesized that will be an imbalance in ribonucleotide/ deoxyribonucleotide 
(rNTP/dNTPs) pool. This imbalance facilitates the misincorporation of 
ribonucleotide in DNA inducing high level of RNaseH2 activity, which is 
responsible for removing the misincorporated ribonucleotide and initiating 
Ribonucleotide Excision Repair RER [38]. From Figure 4.15, we can report an 
overexpression of all three subunits of this enzyme (A,B,and C) in DS cells . 
However, it was only significant increase for subunit A and B with 1.3 and 1.64 
fold increase, respectively while it was not statically significant for subunit C. 
Figure 4.16, we can see that Folate level was significantly lower in DS cell in 
compared to NDS cell even though both cell lines were grown in media 
supplemented with Folic acid. Interestingly, another study showed an increase of 
CBS gene in folate-depleted cells [50]. 
Since we proposed the impact of folate trap induced by the hyper activity 
of CBS, it is crucial to examine the impact of folate depletion on normal 
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lymphocyte cells. Figure 4.9 and Figure 4.10 show that folate depletion depletes 
the intercellular level of folate and reduces dNTP levels in normal B-lymphocytes. 
This finding from Thomas Kunkel’s lab that rNTP misincorporation is more likely 
to happen when cellular concentrations of dNTPs are low [51]. This reduction of 
dNTPs affects the balanced ratio of dNTPs:rNTPs causing more opportunity for 
ribonucleotides to be misincorporated in the DNA, which would hypothesized to 
trigger RNaseH2 activity for removal and repair. RNaseH2 is multimeric 
compromised of three subunits, A, B, and C, and the loss of any of three subunits 
results in reduced activity of RNaseH2 [37,38]. It has been found that ablation of 
RNaseH2B in mice causes replication stress, embryonic deadliness, and 
micronuclei creation [38]. Figure 4.14, we see a significant increase in RNaseH2 
gene expression in both A and B subunits with 1.9 and 1.7 fold, respectively, in 
folate depleted cells FD comparing to the Folate added cells FA; however, there 
was no statically significant difference for subunit C even though the expression 
was 1.5 fold higher FD cells than FA cells. This elevation of RnaseH2 expression 
was an indicator of ribonucleotide misincorporation in DNA that triggers 
RNaseH2 activity for removal and repair by RER pathway [38,41]. 
As we mentioned previously, DNA damage that occurs upon AID gene 
activity of deamination of cytosine to uracil trigger UDG activity to remove the 
altered base recruiting BER protein for further repair of the damage. We 
examined the effect of folate depletion on BER capacity subsequent the DNA 
damage by measuring the expression of AID, UNG2, and POLβ genes. From 
Figure 4.11 and Figure 4.12, Folate depletion significantly induces AID activity 
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by 4 fold higher in FD cells than FA cells, and induces UNG2 significantly in FD 
cells more than 1.7 fold as well. Also, from figure 4.13, Polβ expression was 
elevated 2.4 fold in FD cells comparing to FA cells. These observations could be 
explained by the role of folate depletion in inducing uracil misincorporation in 
lymphocyte DNA [61], which in turn triggers UDG for further removal of uracil and 
then repairing the abasic site by subsequent BER mechanism. This explanation 
could be applied to the increase level of POLβ expression in response to Folate 
depletion. It appears that centroblast B cells have evolved a mechanism to 
suppress Polβ activity where the mutation is required for antibodies development 
during Somatic hypermutation SHM since POLβ is error free repair polymerase. 
However, POLβ is highly required in the rest of the genome for faithful repair. AID 
is inducing mutation in many genes; mutations induced in non-Ig genes are 
faithfully repaired in an error-free way [18]. 
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CHAPTER	  6:	  CONCLUSION	  	  
Many studies have explored the impact of an extra copy of chromosome 
21 on DNA repair capacity in DS, and some of these studies point out to the low 
level of DNA Polymerase β (POLβ), which is a rate limiting enzyme for BER 
activity, associated with low incorporation of thymidine, an indicator of decrease 
DNA synthesis and cell proliferation [35,43,52]. In our study, we investigate more 
to propose a mechanism of folate deficiency and POLβ inhibition derived from 
high dosage of MIR155 and CBS genes by which explains the reduced activity of 
BER and thymidine incorporation in DS lymphocytes. In DS cells, our data show 
that there was a reduction in AID gene expression associated with high 
expression level of MIR155 gene; AID is a direct target of MIR155 in B-
lymphocytes. AID low expression was also associated with low expression level 
of UNG2 and POLβ; albeit, the down regulation of POLβ is not statically 
significant; we might see significant effect with time as other studies indicate the 
progressive reduction of Polβ over time so that we need more investigation to 
see the effect of MIR155 via AID on POLβ directly. However, in normal 
lymphocytes undergoing folate depletion (FD), AID, UNG2, and POLβ were all 
significantly overexpressed. Even though reasonable due to the high level of 
UNG2, POLβ high expression was dislike many reports that indicate low POLβ 
expression in response to FD, which might be specific for Lymphoblastoid cells. 
A notable finding that overexpression of AID in response to FD could be related 
to AID activity as demethylation factor for 5-methyl –cytosine where its activity is 
associated with hypomethylation condition [53], which known to be associated 
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with folate deficiency [54]. Also, FD depleted dNTPs pool which in turn impaired 
dNTP:rNTP pool, and is hypothesized to induce RNaseH2 activity as repair 
mechanism. Interestingly, we find an increase in RNaseH2 activity in DS 
lymphoblastoid cells, which may indicate ribonucleotide misincorporation in DNA 
in DS, and which may be related to the overexpression of CBS gene, further 
connecting FD to DS phenotypes. MIR155 over expression and Folate depletion 
in DS may cooperate to alter dNTP levels and facilitate rNTP misincorporation in 
DNA could explain the low BER capacity and low thymidine incorporation in DS 
lymphocytes. However, more in depth investigations are needed to prove this 
mechanism; studying the impact of DS on enzymes and substrates involved in 
folate one-carbon metabolism, and studying the direct effect of MIR-155 on POLβ 
by directing AID could revels a lot about this proposed mechanism and resolve 
the question about low BER in DS. 
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THE IMPACT OF DOWN SYNDROME AND FOLATE DEPLETION ON 
GENOMIC STABILYZING PATHWAYS OF LYMPHOBLASTOID CELLS 
by 
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Understanding the role of nutrition plays in Down syndrome (DS) could help in the 
development and implementation of strategies that help overcome the negative 
consequences phenotypes of Down syndrome. Conserving genome integrity is crucial 
for cells to survive, and thus understanding how genetic defects induce damage to 
genomic DNA and impair subsequent repair of this damage is important. Evidence 
accumulated points to increased DNA damage and mutation accumulation associated 
with a decline in DNA repair capacity, Base Excision Repair (BER) in particular. Thus, 
the successful clinical management of DS resides in understanding the metabolic 
imbalance provoked by overexpression of genes on chromosome 21. In our study, we 
investigate more to propose a mechanism of folate deficiency and POLβ inhibition 
derived from high dosage of MIR155 and CBS genes, which we hypothesized to provoke 
some kind of metabolic imbalance in DS by which may explain the reduced activity of 
BER and reduced thymidine incorporation in DS lymphocytes.  
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